Lot78 Inc (LOTE) 0.0013 $LOTE Lot78, Inc Announces

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Lot78 Inc (LOTE) 0.0013 $LOTE

Lot78, Inc Announces Decision to Deregister its Common Stock
PR Newswire - Fri Dec 12, 3:15PM CST
Lot78, Inc (the "Company"(OTC Pink: "LOTE" today announced that its Board of Directors unanimously approved the termination of the registration of its common stock under the Securities Exchange Act of 1934, as amended. The Company will file a Form 15 with the Securities and Exchange Commission (the "SEC" to effect this termination on or about December 23, 2014.

Lot78 sees 95% increase in its Autumn/Winter Sales
PR Newswire - Thu Dec 11, 8:30AM CST
Lot78 Inc. is pleased to announce today that the Company has increased its winter sales by 95%.

Lot78 Increases Exposure in Germany, Austria and Switzerland
PR Newswire - Wed Dec 10, 8:30AM CST
Lot78, Inc. is pleased to announce today that the Company has secured an agency deal with Prag Agency in Germany.

Lot78 Expands Global Distribution with Turkish Multi Store Retailer Vakko
PR Newswire - Tue Dec 09, 8:30AM CST
Lot78, Inc. is pleased to announce today that the Company has secured retail distribution with Turkish Multi Store retailer "Vakko."

Lot78 Expands Distribution with US Multi Store Retailer Steven Alan
PR Newswire - Thu Oct 16, 11:21AM CDT
Lot78, Inc. is pleased to announce that the Company has secured retail distribution with US multi store retailer Steven Alan.

Lot78 Expands Distribution with Harvey Nichols in Dubai for Autumn/Winter '14
PR Newswire - Wed Oct 15, 10:16AM CDT
Lot78, Inc. is pleased to announce that the Company has secured retail distribution with Harvey Nichols in Dubai.

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Frontera Energy Set to Release Quarterly Financial Results Soon

Updated Category News Views 253

Frontera Energy Announces First Quarter Financial Results Frontera Energy Corporation (TSX: FEC) has exciting news for its shareholders and interested investors. The Company is set to unveil its financial and operational results for the first quarter, wrapping up on March 31, 2025. This significant announcement will occur after the market closes on a forthcoming Thursday...

Continue Reading
The Rising Value of Contrast Media Injectors in Healthcare

Updated Category News Views 133

Exploring the Global Market for Contrast Media Injectors The global market for contrast media injectors is on the verge of substantial growth, with projections indicating it will reach $2.1 billion in the coming years. This anticipated growth, at a compound annual growth rate (CAGR) of 7.8% from 2025 through 2033, is primarily driven by ongoing advances in technology and...

Continue Reading
Beth Wozniak Sells nVent Electric Shares Worth $884K

Updated Category News Views 158

Beth Wozniak's Recent Stock Sale at nVent Electric Beth Wozniak, Chair & CEO of nVent Electric (NYSE:NVT), executed a significant insider sale recently, as revealed in a new SEC filing. This transaction involved the offloading of 7,597 shares, with a total value of approximately $884,822. Such movements in stock ownership often pique the interest of investors, prompting...

Continue Reading
Electoral Impact of Rising Home Prices on Kamala Harris' Campaign

Updated Category News Views 211

The Impact of Home Prices on the Upcoming Election As we approach the presidential election, the role that home prices play in shaping voter sentiments is becoming increasingly evident. Recent research has shown that fluctuations in the housing market can significantly affect how voters make their choices, particularly in crucial battleground states. Current Trends in...

Continue Reading
Iambic Therapeutics Welcomes Michael Secora as CFO and CDO

Updated Category News Views 134

Iambic Therapeutics Welcomes Michael Secora as CFO and CDO Iambic Therapeutics has announced an important leadership change, appointing Michael Secora, Ph.D., as its Chief Corporate Development Officer and Chief Financial Officer. This decision comes as Iambic continues its commitment to pioneering novel medicines through its innovative AI-driven drug discovery platform....

Continue Reading